Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
This Study Tests BI 1467335 in Healthy Japanese and Caucasian Men. The Study Tests How Different Doses of BI 1467335 Are Taken up in the Body and How Well They Are Tolerated
- Status
- COMPLETED
- Phase
- PHASE1
Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung
- Status
- COMPLETED
- Phase
- PHASE2
This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.
- Status
- COMPLETED
- Phase
- PHASE1
INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol
- Status
- COMPLETED
- Phase
- PHASE4
Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan
- Status
- COMPLETED
- Phase
- PHASE1
BI 443651 Methacholine Challenge
- Status
- COMPLETED
- Phase
- PHASE1
Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Health-related Quality of Life in Patients on Anticoagulants
- Status
- COMPLETED
- Phase
- N/A
Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability of BI 685509 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect
- Status
- COMPLETED
- Phase
- PHASE1
This Study Tests How Different Doses of BI 690517 Are Taken up in the Body of Healthy Men. The Study Also Looks at How Food Influences the Amount of BI 690517 in the Blood
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients
- Status
- COMPLETED
- Phase
- PHASE2
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1